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Alternative splicing of nuclear pre-mRNA is essential for generating protein diversity
and regulating gene expression. While many immunologically relevant genes undergo 
alternative splicing, the role of regulated splicing in T cell immune responses is largely 
unexplored, and the signaling pathways and splicing factors that regulate alternative
splicing in T cells are poorly defined. Here, we show using a combination of Jurkat T 
cells, human primary T cells, and ex vivo naïve and effector virus-specific T cells isolated 
after influenza A virus infection that SC35 phosphorylation is induced in response to
stimulatory signals. We show that SC35 colocalizes with RNA polymerase II in activated 
T cells and spatially overlaps with H3K27ac and H3K4me3, which mark transcriptionally 
active genes. Interestingly, SC35 remains coupled to the active histone marks in the
absence of continuing stimulatory signals. We show for the first time that nuclear PKC-θ 
co-exists with SC35 in the context of the chromatin template and is a key regulator of 
SC35 in T cells, directly phosphorylating SC35 peptide residues at RNA recognition
motif and RS domains. Collectively, our findings suggest that nuclear PKC-θ is a novel 
regulator of the key splicing factor SC35 in T cells.
 
 
 
 
 
Keywords: sc35, PKc-theta, alternative splicing, T cells, histone marks, nuclear speckles
inTrODUcTiOn
Alternative splicing of nuclear pre-mRNA transcripts is an essential regulator of eukaryotic gene 
expression. Alternative splicing results in numerous functionally distinct protein isoforms from a 
single gene (1). Pre-mRNA splicing takes place within the spliceosome, a ribonucleoprotein complex 
enriched in pre-mRNA splicing machinery including small nuclear ribonucleoproteins (snRNPs), 
spliceosome subunits, non-snRNP splicing factors, and a plethora of unknown mRNA-regulating 
nuclear factors (2, 3). Upon target transcript binding at specific splice sites, spliceosomes catalyze the 
removal of non-coding introns and exon ligation to produce protein-coding mRNA. A number of 
mechanisms regulate alternative splicing of pre-mRNA, including exon skipping, intron retention, 
and the selective use of 3′ and 5′ splice sites (4). Alternative splicing is a key mechanism for 
generating protein diversity and regulating gene expression and, therefore, plays an important role 
in cell function and development.
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While most research has focused on transcriptional regulation 
of immune responses, alternative splicing of pre-mRNA is an 
emerging theme in the regulation of T cell function (5, 6). Several 
T cell genes, such as CD44 and CD45, undergo alternative splicing 
to produce distinct protein isoforms (7, 8). Furthermore, antigenic 
stimulation alters the pattern of alternative splicing to produce 
significant functional changes in protein expression (8, 9). Recent 
global studies of alternative splicing have identified a novel group 
of genes that undergo activation-induced alternative splicing in T 
cells. Many of these genes encode proteins that are important for 
T cell function, such as RNA-binding proteins and transcription 
factors (10, 11). However, although numerous immunologically 
relevant genes undergo alternative splicing, the role of alternative 
splicing in T cell memory remains largely unexplored.
SC35 (also known as SRSF2) is a well-characterized splicing 
factor that belongs to the serine/arginine-rich (SR) protein fam-
ily, an important class of splicing regulators. SR proteins have a 
conserved structure characterized by one or two N-terminal RNA 
recognition motifs (RRMs) and a C-terminal arginine-serine-
rich (RS) domain that mediate RNA recognition and protein–
protein interactions within the spliceosome, respectively. SC35 
is exclusively nuclear and, therefore, plays a key role in nuclear 
processes (12). In addition to its crucial function as an alterna-
tive splicing regulator, SC35 also participates in transcriptional 
elongation, RNA stability, mRNA transport, and translation (13, 
14). Furthermore, human SC35 binds exonic splicing enhancers 
under splicing conditions (15).
SC35 is associated with alternative splicing in T cells. For 
example, SC35 regulates alternative splicing of the CD45 mem-
brane receptor (16) and the cell adhesion molecule CD44 in T cells 
(17). Moreover, SC35 is aberrantly expressed in immune-related 
diseases, including SLE, leukemia, and HIV (18–20). SC35 alter-
native splicing also promotes the inclusion and accumulation of 
oncogenes, such as Ron and HPV16 (21, 22). Interestingly, SC35 
dysregulation has been implicated in neurodegenerative diseases, 
suggesting that SC35 may mediate other memory processes, such 
as cognitive memory, in addition to immune responses (23). 
These studies collectively demonstrate SC35’s important role in 
regulating immune responses to infections, but its role in T cell 
memory has not been examined.
Serine/arginine-rich splicing factors are phosphoproteins and 
are regulated by serine phosphorylation in the RS domain (23, 
24). Several protein kinases have been shown to phosphorylate SR 
proteins (25), but the specific kinases that regulate SC35 in T cells are 
unknown. Several members of the protein kinase C (PKC) family, 
an evolutionarily conserved signaling kinase family, have been 
shown to regulate alternative splicing in many cell types including 
T cells (8, 26). Furthermore, both the PKC-α and PKC-δ isoforms 
have been shown to early-activate SC35 in post-natal rat cardiac 
muscle cells (27, 28). In T cells, PKC-θ is a central biochemical 
regulator that is essential for effective immune responses (29, 30). 
We have shown that PKC-θ is a novel nuclear epigenetic enzyme 
as well as a cytoplasmic signaling kinase. Nuclear-anchored 
PKC-θ forms an active signaling complex that directly binds to 
the promoter regions of inducible immune-responsive genes to 
regulate human T cell transcription (31). Given that several PKC 
family members have been shown to regulate alternative splicing 
events in T cells and that PKC-θ plays a key role in T cell function, 
we hypothesize that PKC-θ regulates SC35 in T cells.
Using a combination of Jurkat T cells, human primary T 
cells, and ex vivo naïve and effector virus-specific T cells isolated 
after influenza A virus infection, we show that SC35 phospho-
rylation (SC35p) is induced in response to stimulatory signals. 
Specifically, SC35p colocalizes with RNA polymerase II activated 
T cells and closely associates with H3K27ac (an active enhancer 
mark) and H3K4me3 (a promoter mark), which mark transcrip-
tionally active genes. Interestingly, SC35 remains coupled to the 
active histone marks in the absence of continuing stimulatory 
signals. We show for the first time that nuclear PKC-θ co-exists 
with SC35 in the context of the chromatin template and is a key 
regulator of SC35 in T cells, directly phosphorylating SC35 pep-
tide residues at RRM and RS domains. Collectively, our findings 
suggest that nuclear PKC-θ is a novel regulator of the key splicing 
factor SC35 in T cells.
MaTerials anD MeThODs
Jurkat T cell culture
The Jurkat stimulation model was used as previously described 
(32). The human Jurkat T cell line (Clone E6-1, ATCC® TIB-
152) was cultured in complete 10% fetal bovine serum (FBS) 
RPMI media (Gibco, Life Technologies, Carlsbad, CA, USA). 
Jurkat T cells were either not stimulated (NS) or activated (ST) 
for 2 h at 5 × 105 cells/mL with 24 ng/mL phorbol 12-myristate 
13-acetate (PMA; Sigma-Aldrich, St. Louis, MO, USA; P8139) 
and 1 μM calcium ionophore (I; Sigma-Aldrich, A23187). For 
the stimulation model, previously activated Jurkat T cells were 
washed five times with stimulus-free medium and re-cultured for 
3 days (SW) and subsequently re-stimulated (RST). For inhibitor 
studies, cells were pre-treated with rottlerin (Calbiochem) for 1 h 
prior to activation (31, 33).
PKc-θ and Plasmid Transfections
Two full-length PKC-θ gene sequence constructs were used to 
create two plasmids with active or inactive nuclear localization: 
wild-type PKC-θ (PKCθ WT) or a PKC-θ gene sequence in which 
the non-canonical NLS sequence was inactivated by mutation 
(PKCθ NLS) as previously (34). Briefly, these sequences were 
cloned into the pTracer-CMV vector in frame with a C-terminal 
HA tag. Jurkat T cells were transiently transfected with 15 μg of 
vector-only plasmid, HA-tagged wild-type PKC-θ, or cytoplasmic-
restricted PKC-θ plasmid using the NEON Transfection System 
Kit (Invitrogen, Life Technologies; MPK5000). Cells were 
subsequently stimulated as per the Jurkat stimulation model 
described above and fixed 48  h later in 2% formaldehyde and 
centrifuged onto poly-l-lysine-coated coverslips.
immunofluorescence/image acquisition
Coverslips of T cells were permeabilized by incubation with 1% 
Triton X-100 for 20 min and probed with a mouse antibody to 
phospho-epitopes of human SC35p (Abcam, Cambridge, UK; 
ab11826) followed by a secondary goat antibody to mouse Alexa-
Fluor 568 (Lifetech A-10037). To examine colocalization, T cells 
were probed with an antibody mix of primary mouse antibody 
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to SC35 with rabbit-raised antibodies targeting either human 
RNA-Pol-II-ser2p (Abcam ab5095), H3K4me3 (Merck 07-473), 
H3K27ac (Abcam ab4729), or PKC-θ (Abcam AB63365) fol-
lowed by visualization with a secondary goat antibody to mouse 
immunoglobulins conjugated to Alexa-Fluor 568 and secondary 
antibodies to rabbit immunoglobulins conjugated to Alexa-Fluor 
488 (Lifetech A-11008), respectively.
Coverslips were subsequently mounted on glass microscope 
slides with ProLong Gold anti-fade reagent (Life Technologies). 
Confocal laser scanning microscopy was used to study SC35 
localization as previously described (35). 0.5 μm-spaced images 
were obtained with a Nikon x60 oil immersion lens on a Nikon 
C1 plus confocal system using NIS-Elements AR 3.2 software. 
The final image was obtained by averaging four sequential images 
from the same section at high resolution.
Microscopy Data analysis
Digital confocal images of PKC-θ were analyzed using the Fiji-
ImageJ software (36) to determine the nuclear to cytoplasmic 
fluorescence ratio (Fn/c) using the equation: Fn/c = (Fn − Fb)/
(Fc −  Fb), where Fn is nuclear fluorescence, Fc is cytoplasmic 
fluorescence, and Fb is background fluorescence. A minimum 
of N = 20 cells were analyzed for each sample set. SC35 nuclear 
speckles were analyzed using Fiji-ImageJ software, with the 
nucleus of each cell and total nuclear fluorescence computed by 
the software. The Mann–Whitney non-parametric test (GraphPad 
Prism, GraphPad Software, San Diego, CA, USA) was used to 
determine significant differences between datasets.
Microscopy colocalization analysis
For visualization of colocalization of confocal images, different 
image channels were overlaid in the same Z-plane. Consequently, 
a green and red overlay gave rise to yellow hotspots where 
the two molecules of interest were present in the same pixel 
locations. Statistical analysis of colocalization was performed 
with an intensity correlation coefficient-based method using the 
Colo-2 Fiji-ImageJ plugin with automatic thresholding (36–38). 
Pearson’s colocalization coefficients (PCCs) were collected 
using the ROI manager to select at least 20 individual nuclei 
per sample set. PCC could range from 1 to −1, with 1 denoting 
complete positive correlation, −1 complete negative correlation, 
and 0 no correlation. Data were presented as mean  ±  SEM. 
Statistical analyses were performed with Student’s t-test for paired 
comparisons. Additionally the Plot-Profile feature of Fiji-ImageJ 
was used to record the fluorescence intensity of a pair of antibody 
targets along a line through selected SC35 speckles. For each 
dataset, three speckles were counted for three separate cells and 
plotted with the mean ± SEM.
immunoblot analysis
Immunoblot analysis was performed using primary mouse 
antibody to human SC35p (as above, ab11826) and secondary 
HRP-conjugated goat-anti-mouse antibody on nuclear extracts 
isolated from either primary human CD4+ cells, which were 
untreated (mock) or treated with Life Technologies siRNA PKC-θ 
pool (Life Technologies ID s11122, s11123), PKC-θ siRNA (Santa 
Cruz SC-36252), or nuclear extracts from NS or ST Jurkat T cells 
either untreated or treated with rottlerin. Nuclear extracts of trans-
fected Jurkat T cells were also probed for nuclear expression of 
HA-tagged PKC-θ WT or NLS mutant constructs using a primary 
rabbit antibody to HA (Sigma, H6908). Signals were detected with 
enhanced chemiluminescence reagents (Western Lightning ECL-
Plus, Perkin-Elmer NEL104001) and film exposure. Band intensity 
signals were normalized to the total protein transferred to the blot 
detected using the Quantitative Novex Reversible Protein Stain 
(Thermo Fisher Scientific IB7710) and Image J analysis.
half-Way chiP assays
Half-ChIP assays were performed according to the manufacturer’s 
instructions (Upstate Biotechnology) and as previously described 
for Jurkat T cells (31). Fixation was performed as detailed, and 
fixed chromatin was sonicated with an Ultrasonic processor 
(Qsonica) under optimized conditions to produce average DNA 
fragments of ~500 bp. Prior to antibody addition, samples were 
pre-cleared with salmon sperm DNA-protein A-agarose, and the 
soluble chromatin fraction was incubated overnight at 4°C with 
a primary antibody to PKC-θ and Protein A magnetic beads. 
The beads were washed and incubated with immunoblot loading 
buffer containing beta-mercaptoethanol at 95°C and analyzed as 
above (Immunoblot analysis) with a primary SC35 antibody.
Kinase Profiling on Peptide Microarrays
Active recombinant PKC-θ was provided to JPT Peptide 
Technologies (Berlin, Germany) for kinase profiling on peptide 
microarrays. Unmodified SC35 peptides were chemoselectively 
immobilized on glass slides and incubated with kinase solution in 
the presence of γ-33P-ATP prior to high-resolution phosphorim-
aging. Spot recognition software packages, GenepixPro 7.2 and 
ArrayPro 4.0, were used for data analysis. Peptide constructs that 
displayed a normalized mean signal equal to or greater than two 
SDs above the mean were considered likely positive for phospho-
rylation events. Excel, R, and Python were used to determine the 
statistical significance of sequences and phosphorylation events.
Total rna isolation and Quantitative  
real-Time Pcr
Total RNA was extracted and reverse transcription qPCR was 
performed as previously described (39) using the Maxima First-
Strand cDNA Synthesis Kit (Thermo Scientific, Waltham, MA, 
USA) and 1:20 dilutions of cDNA for the RT-qPCR reaction. 
Ct values were normalized to the housekeeping gene GAPDH. 
Data were expressed as fold changes in message relative to NS. 
The following human TaqMan primer sets were used: SC35 
Hs01923929_s1 (Life Technologies), GAPDH Hs99999905 (Life 
Technologies).
resUlTs
sc35p is induced in Ex Vivo-Derived 
effectors compared to naïve T cells in 
response to Viral infection
Given that the splicing factor SC35 regulates alternative splicing 
in T cells, we initially determined the subcellular distribution 
of SC35 by fluorescence microscopy in the human Jurkat T cell 
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line; cells were either non-stimulated or stimulated with phorbol-
myristate acetate and calcium ionophore (PMA/I), a known PKC 
pathway inducer. The phosphorylated epitope of SC35 (SC35p) 
was detected. Immunofluorescence analysis showed that the total 
nuclear fluorescence of SC35p was substantially increased follow-
ing primary stimulation compared to non-stimulated Jurkat T 
cells (Figure 1A).
We next investigated SC35p dynamics in naïve and effector T 
cells utilizing an established virus infection model in which naive 
(CD44loCD62Lhi) OT-I TCR transgenic CD8+ T cells specific for 
the ovalbumin peptide (OVA257-264) were adoptively transferred 
into congenic C57BL/6J (B6) hosts followed by intranasal (i.n.) 
infection with the A/HKx31-OVA virus (40). Immunofluorescence 
analysis of sort-purified (>99% purity, Figures  S1A,B in 
Supplementary Material) naive (day 0) and effector (day 10) T 
cells was performed. Consistent with the activated Jurkat T cells, 
SC35p was markedly increased in virus-specific effector T cells 
compared to naïve T cells (Figure  1B). Overall, our findings 
suggest that SC35p is induced in a stimulus-dependent manner 
in both the Jurkat T cell line and virus-specific T cells.
sc35p spatially Overlaps with active 
histone Marks in effector T cells in 
response to Viral infection
Highly compacted chromatin structures enriched in nucleosomes 
are transcriptionally silent. Chromatin accessibility is pivotal 
in regulating gene expression and can be orchestrated via a 
number of mechanisms including the addition of PTMs to 
histone proteins (41–43). To determine if SC35p localizes to 
transcriptionally active genes during T cell differentiation 
in response to infection, we double-stained with SC35p and 
histone H3K27ac (Figure 1C), H3K4me3 (Figure 1D), or RNA 
polymerase II-serine2 phosphorylation (Figure  1E), which are 
associated with transcriptionally active or poised genes (44, 45) in 
naïve (day 0) and effector (day 10) OT1 CTLs. SC35p was strongly 
colocalized with all three active marks after differentiation into 
effector CTLs: PCC 0.65 ± 0.01 H3k27ac (C); PCC 0.62 ± 0.01 
H3k4me3 (D); PCC 0.64 ± 0.03 RNA polymerase II-serine2 (E). 
These findings suggest that SC35p co-exists within key regulatory 
regions strongly linked with active enhancers (H3K27ac) and 
gene promoter regions (H3K4me3) in the context of virus-specific 
CTL differentiation.
sc35p remains localized to active 
histone Marks in the absence of 
continuous T cell activation signals
Nuclear accumulation of SC35p correlates with active transcrip-
tion. To assess the time-dependency of nuclear SC35p after 
continuous T cell activation, an experiment was designed (see 
schematic, Figure S2A in Supplementary Material) to measure 
SC35p and its ability to colocalize with active PTMs before (NS), 
during (ST), and after (cells were washed five times to remove 
stimulus and maintained for three divisions; SW) T cell activa-
tion or after RST. Double staining with the active transcription 
marks H3K27ac (Figure 2A), H3K4me3 (Figure 2B), and RNA 
Pol II (Figure  2C) indicated that SC35p strongly colocalized 
with all three histone marks in both primary stimulation (ST) 
(Figures 2A–C; PCC 0.66 ± 0.02 H3k27ac; PCC 0.72 ± 0.017 
H3k4me3; PCC 0.7  ±  0.01 RNA Pol II-ser2) and secondary 
(RST) stimulation conditions (Figures 2A–C; PCC 0.72 ± 0.019 
H3k27ac; PCC 0.67 ±  0.01 H3k4me3; PCC 0.76 ±  0.01 RNA 
Pol II-ser2). Interestingly, this favorable colocalization was 
also observed in the absence of ongoing stimulation in SW 
Jurkat cells (Figures 2A–C PCC 0.0.54 ± 0.016 H3k27ac; PCC 
0.46 ± 0.03 H3k4me3; PCC 0.71 ± 0.02 RNA Pol II-ser2). In con-
trast, no colocalization of these active transcription marks was 
observed in NS Jurkat T cells. Thus, SC35p is induced following 
primary activation and is maintained with active chromatin 
marks after stimulus withdrawal and further induced follow-
ing secondary stimulation. It should be noted that SC35 gene 
expression was unchanged under all conditions (Figures S3A,B 
in Supplementary Material). These data suggest that primary 
stimulation is required for induction of SC35 phosphorylation 
and for its co-existence with active chromatin marks and this 
association with chromatin is maintained in the absence of 
continued activation signals.
PKc-θ regulates sc35p in  
activated T cells
Several protein kinases capable of phosphorylating SR proteins 
have been described (23, 24, 27, 28). However, the specific SC35-
regulating kinases in T cells have yet to be identified. Given 
that PKC-θ is a critical regulator of gene expression in human 
T cells (29, 30), we speculated that PKC-θ might also regulate 
SC35 expression in Jurkat T cells. Double staining and confocal 
microscopy revealed strong colocalization of PKC-θ and SC35p 
in viral influenza-specific OT-1 CD8+ effector T cells (Figure 3A; 
PCC 0.64 ± 0.013). In contrast, no colocalization was detected 
in naïve OT-1 T cells (Figure 3A, PCC 0.06 ±  0.07). Next, we 
investigated the impact of PKC-θ knockdown on SC35p by 
immunoblotting with anti-SC35p in either mock or PKC-θ 
siRNA1 (Lifetech) and siRNA2 (Santa Cruz)-treated nuclear 
extracts of primary human bulk CD4+ T cells. Both siRNA pools 
substantially inhibited SC35 phosphorylation relative to the 
mock treatment (Figure 3B).
Next, we assessed the impact of PKC-θ catalytic activity on SC35p. 
PKC-θ catalytic activity is necessary for chromatin association 
and inducible gene expression (31). To assess the impact of PKC-θ 
catalytic activity, we used an ATP-competitive PKC-θ inhibitor, 
which has previously shown to inhibit PKC-θ activity in human 
T cells (31, 33). Immunoblotting for SC35p in rottlerin or vehicle 
pre-treated NS and ST Jurkat T cell nuclear extracts displayed 
a significant reduction in SC35p phosphorylation compared to 
the mock-treated cells. Collectively, these data indicate a role for 
PKC-θ kinase activity in the active phosphorylation of SC35 in T 
cells (Figure 3C).
nuclear PKc-Theta and sc35p  
co-exist in Jurkat T cells
We have previously shown that PKC-θ can function as a nuclear 
epigenetic enzyme in T cells as well as a cytoplasmic signaling 
kinase (31). To distinguish the cytoplasmic and nuclear roles 
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FigUre 1 | expression of phosphorylated sc35 in T cells and in primary mouse OT-1 T cells. (a) Jurkat T cells were either unstimulated (NS) or 
PMA/I-activated (ST) for 2 h or (B) naive OT-1 CD8+CD44lo/intermediate T-cells or influenza-specific effector OT-1 CD8+ T cells were fixed and probed with a mouse 
antibody to a phospho-epitope of SC35 followed by visualization with a secondary goat antibody to mouse immunoglobulins conjugated to Alexa-Fluor 568. 
Confocal laser scanning microscopy was used to measure SC35 expression as detailed in the section “Materials and Methods.” Representative images for each 
treatment are shown, with a 10-μm scale bar for (a) and a 5-μm scale bar for (B). Total nuclear fluorescence intensity (NFI) was measured with Fiji-ImageJ. Data 
represent the mean ± SEM, n = 20 for each dataset with significant differences between datasets indicated. Naive OT-1 CD8+CD44lo/intermediate T-cells or influenza-
specific effector OT-1 CD8+ T cells were fixed and probed with a primary mouse antibody to a phospho-epitope of human SC35 and primary rabbit antibody to 
H3K27ac (c), H3k4me3 (D), or RNA-Pol-II ser-2 phosphorylation (e) followed by visualization with a secondary goat antibody to mouse immunoglobulins 
conjugated to Alexa-Fluor 568 and secondary antibodies to rabbit immunoglobulins conjugated to Alexa-Fluor 488, respectively. Confocal laser scanning 
microscopy was used to measure expression of SC35 and H3K27ac, H3k4me3, or RNA-Pol-II ser-2 as described in the section “Materials and Methods.” 
Representative images for each treatment are shown with a 5-μm scale bar. Channels were overlaid to examine colocalization of the antibody targets. Pearson’s 
colocalization coefficient (PCC) and mean fluorescent intensity line scans were calculated with Fiji-ImageJ as described in the section “Materials and Methods.” Data 
represent the mean ± SEM, n = 20 for each dataset with significant differences between datasets indicated. Red = SC35p; green = H3K27ac, H3k4me3, or 
RNA-Pol-II-ser2; and yellow = visual overlap between the fluorescence signals.
FigUre 2 | interplay between sc35p, histone PTMs, and rna-Pol-ii ser2 in the Jurkat T cell model.  
 (Continued)
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FigUre 3 | interplay between PKc-θ and sc35 phosphorylation. (a) Naive OT-1 CD8+CD44lo/intermediate T-cells or influenza-specific effector OT-1 CD8+ T-cells 
were fixed and probed with a primary mouse antibody to a phospho-epitope of SC35 and primary rabbit antibody to PKC-θ followed by visualization with a 
secondary goat antibody to mouse immunoglobulins conjugated to Alexa-Fluor 568 and secondary antibodies to rabbit immunoglobulins conjugated to Alexa-Fluor 
488, respectively. Confocal laser scanning microscopy was used to measure expression of SC35 and PKC-θ. Representative images for each stimulation point are 
shown with a 5-μm scale bar. Channels were overlaid to examine colocalization of the antibody targets. Pearson’s colocalization coefficient (PCC) and mean 
fluorescent intensity line scans were calculated with Fiji-ImageJ as described in the section “Materials and Methods.” Data represent the mean ± SEM, n = 20 for 
each dataset with significant differences between datasets indicated. Red = SC35; green = PKC-θ; and yellow = visual overlap between the fluorescence signals. 
(B) Cell lysates of primary human CD4+ cells were untreated (mock) or treated with PKC-θ siRNA1 (Life Technologies) or siRNA2 (Santa Cruz). Effect on SC35 was 
analyzed by immunoblotting with a mouse raised primary antibody to a phospho-epitope of SC35, measuring band intensity with Fiji-ImageJ for each sample. A 
representative image of SC35 labeling for three separate experiments (n = 3) is displayed (labeled SC35), with the mean intensity plotted with significant differences 
displayed for each treatment along with a representative loading control (LC) as described in the section “Materials and Methods.” The effect of rottlerin treatment 
(c), a PKC-θ-specific kinase inhibitor, on SC35 phosphorylation was also examined by immunoblotting as described above. A representative loading control (LC) is 
shown along with a representative SC35p-probed blot for three separate experiments (n = 3). The mean intensity is plotted with significant differences displayed for 
each treatment.
Jurkat T cells stimulated as described in the section “Materials and Methods” (NS, no stimulation; ST, stimulation; SW, stimulus withdrawal; RST, re-stimulation) were 
fixed and probed with a primary mouse antibody to a phospho-epitope of human SC35 and primary rabbit antibody to H3K27ac (a), H3k4me3 (B), or RNA-Pol-II 
ser-2 (c) followed by visualization with a secondary goat antibody to mouse immunoglobulins conjugated to Alexa-Fluor 568 and secondary antibodies to rabbit 
immunoglobulins conjugated to Alexa-Fluor 488, respectively. Confocal laser scanning microscopy was used to measure expression of SC35p and H3K27ac, 
H3k4me3, or RNA-Pol-II-ser-2. Representative images for each stimulation point are shown with a 10-μm scale bar. Channels were overlaid to examine 
colocalization of the antibody targets. Pearson’s co-localizaton coefficient (PCC) and mean fluorescent intensity line scans were calculated with Fiji-ImageJ as 
described in the section “Materials and Methods.” Data represent the mean ± SEM, n = 20 for each dataset with significant differences between datasets indicated. 
Red = SC35; green = H3K27ac, H3k4me3, or RNA-Pol-II-ser2; and yellow = visual overlap between the fluorescence signals.
FigUre 2 | continued
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of PKC-θ in SC35p expression, previously validated PKC-θ 
constructs (34), a HA tagged wild-type PKC-θ (HAPKC-θ WT) 
or a HA tagged PKC-θ with a mutated NLS (HAPKC-θ NLS), 
were expressed in Jurkat T cells. Consistent with our previous 
observations, HAPKC-θ NLS was significantly cytoplasmic 
restricted compared to the HAPKC-θ WT in the Jurkat and HUT 
T cell lines (Figures  4A–C). Next, to determine the effect of 
nuclear PKC-θ regulation on SC35 phosphorylation in Jurkat T 
cells, the subcellular distribution of SC35p was analyzed in Jurkat 
T cells transfected with vector-only (mock) control and PKC-θ 
plasmid constructs and then stimulated 48 h after transfection in 
the Jurkat stimulation model. Total nuclear SC35p fluorescence 
significantly increased in all HAPKC-θ WT-treated cells (Figure 4E) 
overexpressing PKC-θ compared to mock constructs (Figure 4D), 
suggesting that PKC-θ plays a role in speckle formation. In 
contrast, transfection with the HAPKC-θ NLS mutant resulted in 
FigUre 4 | localization of PKc-θ in T cells and effect on sc35p.  
 (Continued)
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The full-length PKC-θ wild-type gene sequence (HAPKC-θ WT) and the NLS mutation (HAPKC-θ NLS) were cloned into the pTracer-CMV vector in frame with a 
C-terminal HA tag. Transfected Hut-78 T cells (a) and Jurkat T cells (B) and were fixed and probed with a rabbit antibody to the HA-tag followed by visualization 
with a secondary goat antibody to rabbit immunoglobulins conjugated to Alexa-Fluor 568. Confocal laser scanning microscopy was also used to assess PKC-θ 
localization as described in the section “Materials and Methods.” Representative images for each construct are shown. Fn/c values for each construct are shown 
with significant differences between datasets indicated. Data represent the mean ± SEM, n = 20 for each dataset. (c) Jurkat T cells were transfected, stimulated, 
and nuclear extracts created to examine nuclear localization of the PKC-θ wild-type and PKCθNLS mutant. A representative immunoblot image of nuclear extracts 
showing HAPKC-θ localization in the nucleus is shown. Jurkat T cells were transfected as described in the section “Materials and Methods” and subsequently 
stimulated (NS, non-stimulated; ST, stimulated; RST, re-stimulated). Cells were fixed and probed with a mouse antibody to a phospho-epitope of human SC35 with 
secondary antibodies to mouse immunoglobulins conjugated to Alexa-Fluor 568. Confocal laser scanning microscopy was used to study SC35p expression in HA 
tag-positive cells. Representative images for each construct are shown with a 10-μm scale bar: (D) vector only (VO), (e)HAPKC-θ WT, and (F)HAPKC-θ NLS. Total 
nuclear fluorescence values for each construct are shown with significant differences between datasets indicated (g). Data represent the mean ± SEM, n = 20 for 
each dataset. (h) Nuclear extracts were made from Jurkat T cells stimulated as previously described (NS, no stimulation; ST, stimulation; SW, stimulus withdrawal; 
RST, re-stimulation) and subjected to half-way CHIP using PKC-θ pull down or a no antibody control. Samples were probed with a primary mouse antibody to a 
phospho-epitope of human SC35 as described in the section “Materials and Methods”; representative bands are shown. SC35 band intensity was plotted using 
Fiji-ImageJ software minus background for n = 3 with mean ± SEM.
FigUre 4 | continued
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diminished SC35p in the Jurkat T cells (Figure 4F), as indicated 
in the nuclear fluorescence data (Figure 4G).
To determine whether nuclear PKC-θ and SC35 co-exist in the 
nucleus in the context of the chromatin template, we performed 
PKC-θ half-way ChIP on Jurkat T cell nuclear extracts. Endogenous 
PKC-θ and SC35p were associated in Jurkat T cells, particularly 
in RST Jurkat T cells (Figure 4H). Interestingly, co-existence of 
both proteins was maintained in SW cells following stimulus 
withdrawal (Figure 4H), but this association increased following 
secondary stimulation (Figure 4H). Taken together, PKC-θ and 
SC35p co-exist in the proximity of chromatin within the nuclear 
compartment of T cells.
PKc-θ Directly Phosphorylates sc35 at 
regulatory Domains
To determine whether PKC-θ directly phosphorylates SC35 
residues, an in vitro kinase assay was performed in which SC35 
peptide constructs were incubated with active PKC-θ in the pres-
ence of radiolabeled γ33P-ATP in an array-based format.
Of the 51 peptide constructs tested, 14 were positive for phos-
phorylation events (Figure 5A). SC35 contains two long stretches 
of RS repeats and an RRM domain (12). Sequence analysis of these 
14 peptides showed that all but two of the positive peptides local-
ized to the long tract dipeptide RS domains (Table 1). In contrast, 
peptides 5 and 9 localized to the RRM domain at the N-terminal. 
The peptide with the strongest phosphorylation signal (peptide 1) 
was located in the RS domain (171AA–186AA; Figure 5B).
We also examined the relationship between phosphorylated 
peptides and recently identified PKC-θ motifs (Figure 5C) (46). 
The strongest peptide signals (peptides 1, 2, and 3) contained 
seven PKC-θ phosphorylation motifs. Furthermore, the other 11 
phosphorylation-positive peptides also contained regions that 
correlated with putative PKC-θ phosphorylation motifs. Overall, 
our data demonstrate that the nuclear PKC-θ kinase directly 
phosphorylates SC35 at both RMM and RS regulatory domains.
DiscUssiOn
The contribution of alternative splicing to T cells is an emerging 
area of immunological research. The interplay between the 
transcriptional splicing machinery and the chromatin landscape 
is poorly defined, particularly in T cells. Here, we show that 
the key splicing factor SC35 is induced in response to T cell 
stimulatory signals. Specifically, we show that phosphorylated 
form of SC35 (SC35p) is enriched following T cell activation in 
Jurkat T cells, human primary T cells, and ex vivo effector virus-
specific T cells isolated after influenza A virus infection. We show 
that SC35p colocalizes with RNA polymerase II in activated T 
cells and spatially overlaps with H3K27ac and H3K4me3, which 
mark transcriptionally active genes in primary and secondary 
T cell activation. PKC-θ is a novel regulator of SC35 expression 
in T cells that directly phosphorylates SC35 at its key regulatory 
regions.
Several PKC family members play a role in mRNA splicing 
in other cell types (8, 26–28). Here, we show that PKC-θ is a 
key regulator of SC35 in human T cells, and for the first time 
demonstrate that nuclear PKC-θ regulates SC35 phosphorylation 
in T cells. The increase in SC35 phosphorylation in PKC-θ 
WT-transfected T cells suggests that phosphorylation by PKC-θ 
initiates speckle formation and an increase in SC35p signal and 
concentration. Interestingly, DAG kinase has also been shown to 
localize in the nucleus (47), and it would be interesting to know 
whether it is located in a similar active transcription complex 
as PKC-θ in T cells. In addition, PIPKs, part of a PKC co-factor 
pathway, associate with nuclear speckles, further suggesting that 
PKCs and PKC co-factors play a role in splicing (48).
We demonstrate that PKC-θ directly phosphorylates SC35 
at RS and RRM domains. Furthermore, our data with a PKC 
catalytic inhibitor and siRNA knockdown suggests that PKC-θ 
is critical for SC35 phosphorylation in T cells. The RS domain 
mediates protein–protein interactions, such as subcellular 
localization (49), nuclear export, and retention signals (12), and 
functions as a splicing activator (50). We also identified two 
PKC-θ-phosphorylated peptides that lie in the RRM domain. The 
RRM domain recognizes RNA recognition sequencing and has 
been shown to mediate subcellular localization (49) and alterna-
tive splicing specificity (51, 52). Future studies will be required 
to address the essential nature of these novel PKC-θ-targeted 
phosphorylation sites within key SC35 domains in T cells. It has 
been reported that Tip60 acetylation of SC35 at lysine residue 
52 promotes proteasomal degradation of splicing factors and 
reduces SC35 phosphorylation (53). Given that Lysine 52 is in 
FigUre 5 | identification of phosphorylated residues on the sc35 splicing protein. (a) Mean peptide signal and all SC35 peptide constructs used to 
examine SC35 for phosphorylation by PKC-θ. The red bar indicates the cut-off for positive signal for phosphorylation. The distribution curve for SC35 peptide 
phosphorylation is also displayed: the y-axis is the kernel density estimate of the normalized phosphorylation signal intensities on the x-axis, with anything 
equal to or greater than the red bar (2 × SD above the mean) considered a positive phosphorylation event. (B) The amino acid sequence of SC35 indicating 
the location of the top nine peptides in descending order and their location; the other five peptides correspond to overlaps with the first nine peptide 
locations. Green highlight denotes the RRM domain, the yellow highlight denotes RS dipeptide repeats. Peptides are numbered in order of mean signal 
intensity: red bar is the highest signal, blue bars are the other positive SC35 peptides, and possible serine or threonine phosphorylation residues are 
indicated by red or blue diamonds. (c) The top three peptide sequences and their overlap with the SC35 amino acid sequence. Hutti et al. (46) reported a 
serine/threonine specific motif for PKC-θ-mediated phosphorylation; using this information, the section of SC35 that scored the top three hits for peptide 
phosphorylation signals was analyzed for these motifs. Seven separate phosphorylation motifs were identified.
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proximity to putative PKC-θ phosphorylation sites in the RRM 
domain, and siRNA and rottlerin inhibitor experiments implicate 
PKC-θ kinase activity in SC35 RRM domain phosphorylation, an 
intriguing possibility exists that this phosphorylation by PKC-
θ may play a role in preserving the SC35 nuclear speckle from 
degradation in T cells.
Memory T cells elicit fast and enhanced secondary immune 
responses upon antigen exposure to mount effective adaptive 
immune responses to infectious diseases and cancers (54–56). 
Enhanced memory T cell function is underpinned by the rapid 
induction of a distinct cohort of genes in response to antigenic 
re-challenge (57–59). This transcriptional response is greater and 
more robust in memory than naïve T cells. Furthermore, memory 
T cells “remember” previous transcriptional responses for decades 
in humans in the absence of antigen (60). Although the rapid recall 
responses of memory T cells are well documented, the signaling 
pathways and mechanisms that regulate T cell transcriptional 
TaBle 1 | Mean peptide signals and protein domains, related to Figure 6.
sc35 peptide 
sequence
Mean normalized 
mean
sc35 protein 
domain
Peptide 1 SKSKSSSVSRSRSRS 55,706 6,331 RS domain
Peptide 2 SSSVSRSRSRSRSRS 53,589 4,214 RS domain
Peptide 3 SARRSKSKSSSVSRS 53,504 4,129 RS domain
Peptide 4 SPRRRRRSRSRSRSR 53,345 3,970 RS domain
Peptide 5 LTYRTSPDTLRRVFE 53,132 3,757 RRM domain
Peptide 6 SRSRTRSRSRSTSKS 52,781 3,406 RS domain
Peptide 7 RRSRSPRRRRRSRSR 52,746 3,370 RS domain
Peptide 8 RSRYSRSKSRSRTRS 52,745 3,370 RS domain
Peptide 9 YGRVGDVYIPRDRYT 52,722 3,346 RRM domain
Peptide 10 PPVSKRESKSRSRSK 52,575 3,199 RS domain
Peptide 11 SRSKSRSRTRSRSRS 52,497 3,121 RS domain
Peptide 12 SRSTSKSRSARRSKS 52,475 3,100 RS domain
Peptide 13 SKSRSARRSKSKSSS 52,461 3,086 RS domain
Peptide 14 SRSRSRSRSRSPPPV 52,402 3,026 RS domain
The mean peptide signals for all 14 SC35 peptide constructs above the positive cut-off for 
phosphorylation. The peptide sequence and the protein domain occupied are also tabulated.
FigUre 6 | nuclear PKc-θ as a novel regulator of sc35 in T-cells. Our model of the interaction between PKC-θ and SC35 in the context of TM in Jurkat T cells. Blue 
cylinders represent histones, and the colored ovals represent histone PTMs: red = repressive, purple (H3k27ac), or green (H3k4me3). Light green oval is PKC-θ, red oval is 
RNA-Pol-II, the darker green oval represents various TFs, and the orange oval is SC35p speckles. Upon stimulation, PKC-θ enters the nucleus and binds to a chromatin 
platform incorporating RNA-Pol-II and various transcription factors. At the same time, PKC-θ phosphorylates SC35, relocating the speckle to the site of transcription to 
potentially form a linked complex between the chromatin platform, the splicing speckle, and active histone marks. After stimulus withdrawal, this association between PKC-θ/
TFs, histone PTMs, and SC35 speckles is maintained and expands even further upon re-stimulation to effect massive recruitment of phosphorylated SC35 splicing speckles.
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memory are complex and have yet to be fully elucidated (61–63). 
We show in this study that SC35p colocalizes with RNA Pol II 
and key histone marks in primary and secondary-activated T 
cells. An interesting finding was that SC35p remained closely 
associated with key histone marks in SW Jurkat T cells in spite of 
the absence of activating signals. Furthermore, SC35p and PKC-θ 
co-existed in close proximity to the chromatin platform following 
stimulus withdrawal. The maintenance of SC35 in SW Jurkat T 
cells suggests that SC35 exists in a poised or ready state following 
stimulus withdrawal. This poised state may serve as a transcrip-
tional memory signature that marks genes for rapid transcription 
upon secondary activation. We show that SC35 colocalizes with 
active histone marks H3K27ac and H3K4me3; however, while 
H3K27ac marks active enhancers, H3K4me3 is largely deposited 
at promoter regions (45, 64). Given that H3K4me3 is increased 
in memory T cells and in effector cells at active gene loci (65), the 
role of SC35 at gene enhancers in memory T cells deserves further 
study. Since SC35 is also implicated in chromatin remodeling 
(66), proteomic analysis will be required to explore the interplay 
between the enzymes that regulate T cell memory and SC35 in 
T cells.
We propose a model in which nuclear PKC-θ interacts with 
SC35 in distinct T cell activation states (see Figure  6). Upon 
stimulation, nuclear PKC-θ forms an active transcription 
complex with RNA Pol II as previously described (31). At the 
same time, PKC-θ directly phosphorylates SC35 speckles at RS 
and RRM domains to direct localization of SC35p near active 
gene expression regions, such as H3K27ac-marked enhancers, 
and initiates speckle formation. Following stimulus removal, the 
SC35p speckle and PKC-θ complex are maintained in a poised 
or ready state near accessible chromatin. Reactivation signals 
increase SC35p and further induce phosphorylation of SC35p 
speckles. Together, future studies will be required to provide 
in-depth mechanistic insights into the contribution of SC35p in 
marking genes for rapid reactivation.
Given that PKC-θ regulates the key splicing factor SC35, 
future studies should aim to address the role of PKC-θ in alterna-
tive splicing utilizing global, high-throughput methods, such as 
RNA sequencing. It will also be important to determine if nuclear 
kinase-regulated splicing is unique to T cells or whether other 
kinases, such as Akt and CDK5/p35, which mediate CD8+ T cell 
differentiation and neuronal development, play a nuclear role 
in splicing. Unraveling the role of alternative splicing in T cell 
regulation is likely to be useful in translational applications in 
autoimmune diseases and cancer biology.
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